Pontocerebellar hypoplasia type 2

From WikiMD's WELLNESSPEDIA

Alternate names[edit]

Progressive microcephaly from birth extrapyramidal dyskinesia chorea epilepsy; PCH2

Definition[edit]

Pontocerebellar hypoplasia type 2 (PCH2) is a rare condition that affects the development of the brain.

Cause[edit]

PCH2 is caused by changes (mutations) in the TSEN54, TSEN2, TSEN34, or SEPSECS gene.

Inheritance[edit]

Autosomal recessive inheritance, a 25% chance

It is inherited in an autosomal recessive manner.

Signs and symptoms[edit]

Clinical presntation[edit]

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.

5%-29% of people have these symptoms

  • Cerebral atrophy(Degeneration of cerebrum)
  • Cerebral cortical atrophy(Decrease in size of the outer layer of the brain due to loss of brain cells)
  • Death in childhood
  • Simplified gyral pattern
  • Ventriculomegaly

Diagnosis[edit]

The diagnosis of TSEN54-PCH is suspected in children with characteristic neuroradiologic and neurologic findings, and is confirmed by the presence of biallelic TSEN54 pathogenic variants.[1][1].


Treatment[edit]

  • Treatment of irritability, swallowing incoordination, epilepsy, and central visual impairment is symptomatic.
  • Physiotherapy can be helpful. [2][2].
  • Adequate hydration during prolonged periods of high fever may help avoid rhabdomyolysis.

References[edit]

  1. van Dijk T, Baas F. TSEN54 Pontocerebellar Hypoplasia. 2009 Sep 8 [Updated 2020 May 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK9673/
  2. van Dijk T, Baas F. TSEN54 Pontocerebellar Hypoplasia. 2009 Sep 8 [Updated 2020 May 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK9673/

NIH genetic and rare disease info[edit]

Pontocerebellar hypoplasia type 2 is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.